Interactomics Analyses of Wild-Type and Mutant A1CF Reveal Diverged Functions in Regulating Cellular Lipid Metabolism-Reference-Cited by-同舟云学术

Interactomics Analyses of Wild-Type and Mutant A1CF Reveal Diverged Functions in Regulating Cellular Lipid Metabolism

Published:2020-08-10 Issue:10 Volume:19 Page:3968-3980
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Xu Yu-Xin¹^ORCID,Stanclift Caroline²,Nagai Taylor Hanta¹,Yu Haojie³,Vellarikkal Shamsudheen Karuthedath¹,Deik Amy⁴,Bullock Kevin⁴,Schenone Monica²,Cowan Chad³,Clish Clary B.⁴^ORCID,Carr Steven²,Kathiresan Sekar¹

Affiliation:

1. Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, United States

2. The Proteomics Platform, Broad Institute, Cambridge, Massachusetts 02142, United States

3. Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States

4. The Metabolomics Program, Broad Institute, Cambridge, Massachusetts 02142, United States

Funder

National Heart, Lung, and Blood Institute

American Heart Association

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.0c00235

Reference36 articles.

1. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine

2. Apolipoprotein B-48 Is the Product of a Messenger RNA with an Organ-Specific In-Frame Stop Codon

3. Characterization of the apolipoprotein B mRNA editing activity in enterocyte extracts.

4. In vitro apolipoprotein B mRNA editing: identification of a 27S editing complex.

5. Molecular Cloning of an Apolipoprotein B Messenger RNA Editing Protein

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromatin regulator SMARCAL1 modulates cellular lipid metabolism;Communications Biology;2023-12-21

2. Integrative analysis of triphenyl phosphate: contextual interpretation of bladder cancer cohort;Frontiers in Oncology;2023-10-05